CLASS II Device recall · Reported 9 Apr 2014 · FDA Enforcement Report

RayStation Radiation Therapy Treatment Planning System recalled

Raysearch Laboratories AB is recalling RayStation Radiation Therapy Treatment Planning System, distributed in 15 states. The recall was initiated on 6 Feb 2014 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesMODEL #(s): 2.5, 3.0, 3.5 and 4.0; VERSIONS: 2.5.1.89, 3.0.0.251, 3.5.0.16, 3.5.1.6, 4.0.0.14, 4.0.1.4, 4.0.2.9
Quantity recalled151 units Total (88 units domestically & 63 units internationally)

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1307-2014
FDA event ID
67504
Recalling firm
Raysearch Laboratories AB, Stockholm, N/A
Classification
Class II
Status
Terminated
Recall initiated
6 Feb 2014
FDA classified
28 Mar 2014
Reported
9 Apr 2014
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Device Malfunction
Device type
Medical Software

Timeline

6 Feb 2014Recall initiated by company
28 Mar 2014Classified by FDA+50 days
9 Apr 2014Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Potential for dose errors due to software program errors.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

RayStation Radiation Therapy Treatment Planning System, models 2.5, 3.0, 3.5 and 4.0; a software system designed for treatment planning and analysis of radiation therapy.

Where it was distributed

Worldwide Distribution - US including the states of NY, OH, MD, CT, CO, TN, IL, AZ, MS, NJ, PA, DE, FL, CA and WA., and the countries of New Zealand, Australia, Republic of Korea, China, Italy, Germany, Norway, Belgium, Switzerland, United Kingdom and Spain.

ArizonaCaliforniaColoradoConnecticutDelawareFloridaIllinoisMarylandMississippiNew JerseyNew YorkOhioPennsylvaniaTennesseeWashington

Questions about this recall

Why was it recalled?

Potential for dose errors due to software program errors.

Which lots are affected?

MODEL #(s): 2.5, 3.0, 3.5 and 4.0; VERSIONS: 2.5.1.89, 3.0.0.251, 3.5.0.16, 3.5.1.6, 4.0.0.14, 4.0.1.4, 4.0.2.9

Where was it sold?

Worldwide Distribution - US including the states of NY, OH, MD, CT, CO, TN, IL, AZ, MS, NJ, PA, DE, FL, CA and WA., and the countries of New Zealand, Australia, Republic of Korea, China, Italy, Germany, Norway, Belgium, Switzerland, United Kingdom and Spain.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Raysearch Laboratories AB

All 115

Other Medical Software recalls

All 903